Phase I/II trial of oncolytic reovirus (Reolysin) in combination with carboplatin/paclitaxel in patients (pts) with advanced solid cancers

被引：0
|
作者：
Karapanagiotou, E. [1 ,2 ,3 ,4 ]
Pandha, H. S. [1 ,2 ,3 ,4 ]
Hall, G. [1 ,2 ,3 ,4 ]
Chester, J. [1 ,2 ,3 ,4 ]
Melcher, A. [1 ,2 ,3 ,4 ]
Coffey, M. [1 ,2 ,3 ,4 ]
de Bono, J. [1 ,2 ,3 ,4 ]
Gore, M. E. [1 ,2 ,3 ,4 ]
Nutting, C. M. [1 ,2 ,3 ,4 ]
Harrington, K. J. [1 ,2 ,3 ,4 ]
机构：
[1] Royal Marsden Hosp, NHS Fdn Trust, London SW3 6JJ, England
[2] Univ Surrey, Guildford GU2 5XH, Surrey, England
[3] Leeds Inst Mol Med, Leeds, W Yorkshire, England
[4] Oncolyt Biotech Inc, Calgary, AB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14519
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors
    Mary E. R. O’Brien
    Debashis Sarker
    Jaishree Bhosle
    Kiruthikah Thillai
    Timothy A. Yap
    Martina Uttenreuther-Fischer
    Karine Pemberton
    Xidong Jin
    Sabrina Wiebe
    Johann de Bono
    James Spicer
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 757 - 766
  • [22] A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors
    O'Brien, Mary E. R.
    Sarker, Debashis
    Bhosle, Jaishree
    Thillai, Kiruthikah
    Yap, Timothy A.
    Uttenreuther-Fischer, Martina
    Pemberton, Karine
    Jin, Xidong
    Wiebe, Sabrina
    de Bono, Johann
    Spicer, James
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (05) : 757 - 766
  • [23] Phase I study of olaparib in combination with carboplatin and/or paclitaxel in patients with advanced solid tumors.
    van der Noll, Ruud
    Ang, Joo Ern
    Jager, Agnes
    Marchetti, Serena
    Mergui-Roelvink, Marja
    De Bono, Johann Sebastian
    Lolkema, Martijn
    Brunetto, Andre
    Arkenau, Hendrik-Tobias
    De Jonge, Maja J.
    van der Biessen, Diane
    Tchakov, Ilian
    Bowen, Karin
    Schellens, Jan H. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] Phase I study of ombrabulin in combination with paclitaxel and carboplatin in Japanese patients with advanced solid tumors
    Matsumoto, Koji
    Sunaga, Yoshinori
    Ecstein-Fraisse, Evelyne
    Fujiwara, Keiichi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (04) : 586 - 593
  • [25] SUNITINIB IN COMBINATION WITH CARBOPLATIN (C) PLUS PACLITAXEL (P) IN PATIENTS (PTS) WITH ADVANCED SOLID TUMORS (STS): PHASE I STUDY RESULTS
    Heath, E. I.
    Blumenschein, G. R.
    Cohen, R. B.
    LoRusso, P. Mucci
    LoConte, N.
    Kim, S. T.
    Chao, R.
    Wilding, G.
    ANNALS OF ONCOLOGY, 2008, 19 : 156 - 156
  • [26] Recombinant human angiostatin (rhAngiostatin) in combination with paclitaxel and carboplatin in patients (pts) with advanced NSCLC: Preliminary results of a phase II trial.
    Hanna, NH
    Estes, D
    Cress, A
    Sidor, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 642S - 642S
  • [27] A phase I trial of oral administration of panobinostat in combination with paclitaxel and carboplatin in patients with solid tumors
    Jones, Suzanne F.
    Infante, Jeffrey R.
    Thompson, Dana S.
    Mohyuddin, Adil
    Bendell, Johanna C.
    Yardley, Denise A.
    Burris, Howard A., III
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (03) : 471 - 475
  • [28] A phase I trial of oral administration of panobinostat in combination with paclitaxel and carboplatin in patients with solid tumors
    Suzanne F. Jones
    Jeffrey R. Infante
    Dana S. Thompson
    Adil Mohyuddin
    Johanna C. Bendell
    Denise A. Yardley
    Howard A. Burris
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 471 - 475
  • [29] Phase I study of combination vemurafenib, carboplatin, and paclitaxel in patients ( pts) with BRAF-mutant advanced cancer
    Kato, Shumei
    Janku, Filip
    Piha-Paul, Sarina Anne
    Naing, Aung
    Karp, Daniel D.
    Tsimberidou, Apostolia Maria
    Subbiah, Vivek
    Zinner, Ralph
    Hwu, Wen-Jen
    Javle, Milind M.
    Parkhurst, Kristin L.
    Ramzanali, Nishma M.
    Kurzrock, Razelle
    Meric-Bernstam, Funda
    Chae, Young Kwang
    Kim, Kevin
    Falchook, Gerald Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [30] A PHASE I TRIAL OF INTRAVENOUS ONCOLYTIC REOLYSIN® IN PATIENTS WITH BRAIN TUMOURS
    Jebar, A.
    West, E.
    Scott, K.
    Thomson, S.
    Corns, R.
    Mathew, R.
    SivaKumar, G.
    Coffey, M.
    Nuovo, G.
    Rose, A.
    Ralph, C.
    Twelves, C.
    Anthoney, A.
    Griffin, S.
    Short, S.
    Melcher, A.
    NEURO-ONCOLOGY, 2014, 16
12345